维奈克拉
Tier B — Position earlyVenetoclax · all drugs expiring in 2030 →
Targets:BCL2
Brand:Venclyxto、Venclexta、唯可来
Indications (approved):急性髓细胞样白血病、慢性淋巴细胞白血病
Regional status
Synthetic routes & intermediates3 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

| Code | CAS No. | Intermediate |
|---|---|---|
| VENE-001 | 183208-35-7Available | 5-bromo-1H-pyrrolo[2,3-b]pyridine |
| VENE-002 | 858116-66-2Available | 5-bromo-1-(triisopropylsilyl)-1H-pyrrolo[2,3-b]pyridine |
| VENE-003 | 685514-01-6Available | 1-(triisopropylsilyl)-1H-pyrrolo[2,3-b]pyridin-5-ol |
| VENE-004 | 106614-28-2Available | methyl 2,4-difluorobenzoate |
| VENE-005 | 1235865-75-4Available | methyl 2-((1H-pyrrolo[2,3-b]pyridin-5-yl)oxy)-4-fluorobenzoate |
| VENE-006 | 1228780-72-0Available | 1-((4'-chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)methyl)piperazine |
| VENE-007 | 1235865-76-5Available | methyl 2-((1H-pyrrolo[2,3-b]pyridin-5-yl)oxy)-4-(4-((4'-chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)methyl)piperazin-1-yl)benzoate |
| VENE-008 | 1235865-77-6Available | 5-bromo-1H-pyrrolo[2,3-b]pyridine |
| VENE-009 | 1228779-96-1Available | 5-bromo-1-(triisopropylsilyl)-1H-pyrrolo[2,3-b]pyridine |
| VENE-010 | 32767-46-7Available | methyl 4,4-dimethyl-2-oxocyclohexane-1-carboxylate |
| VENE-011 | 1228780-46-8Available | methyl 4,4-dimethyl-2-(((trifluoromethyl)sulfonyl)oxy)cyclohex-1-ene-1-carboxylate |
| VENE-012 | 1679-18-1Available | (4-chlorophenyl)boronic acid |
| VENE-013 | 1228780-49-1Available | methyl 4'-chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-carboxylate |
| VENE-014 | 1228780-51-5Available | (4'-chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)methanol |
| VENE-015 | 57260-71-6Available | tert-butyl piperazine-1-carboxylate |
| VENE-016 | 1228780-71-9Available | tert-butyl 4-((4'-chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)methyl)piperazine-1-carboxylate |

| Code | CAS No. | Intermediate |
|---|---|---|
| VENE-008 | 1235865-77-6Available | 5-bromo-1H-pyrrolo[2,3-b]pyridine |
| VENE-009 | 1228779-96-1Available | 5-bromo-1-(triisopropylsilyl)-1H-pyrrolo[2,3-b]pyridine |
| VENE-012 | 1679-18-1Available | (4-chlorophenyl)boronic acid |
| VENE-015 | 57260-71-6Available | tert-butyl piperazine-1-carboxylate |
| VENE-016 | 1228780-71-9Available | tert-butyl 4-((4'-chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)methyl)piperazine-1-carboxylate |
| VENE-017 | 105931-73-5Available | 4-bromo-2-fluoro-1-iodobenzene |
| VENE-018 | 889858-12-2Available | - |
| VENE-019 | 98549-88-3Available | 1H-pyrrolo[2,3-b]pyridin-5-ol |
| VENE-020 | 1628047-84-6Available | tert-butyl 2-((1H-pyrrolo[2,3-b]pyridin-5-yl)oxy)-4-bromobenzoate |
| VENE-021 | 1228780-72-0Available | 1-((4'-chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)methyl)piperazine |
| VENE-022 | 932710-63-9Available | 4-(di-tert-butylphosphanyl)-N,N-dimethylaniline |
| VENE-023 | 1628047-90-4Available | tert-butyl 2-((1H-pyrrolo[2,3-b]pyridin-5-yl)oxy)-4-(4-((4'-chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)methyl)piperazin-1-yl)benzoate |
| VENE-024 | 2979-19-3Available | 3,3-dimethylcyclohexanone |
| VENE-025 | 1228943-80-3Available | 2-chloro-4,4-dimethylcyclohex-1-ene-1-carbaldehyde |
| VENE-026 | 1228837-05-5Available | 4'-chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-carbaldehyde |

| Code | CAS No. | Intermediate |
|---|---|---|
| VENE-007 | 1235865-76-5Available | methyl 2-((1H-pyrrolo[2,3-b]pyridin-5-yl)oxy)-4-(4-((4'-chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)methyl)piperazin-1-yl)benzoate |
| VENE-008 | 1235865-77-6Available | 5-bromo-1H-pyrrolo[2,3-b]pyridine |
| VENE-009 | 1228779-96-1Available | 5-bromo-1-(triisopropylsilyl)-1H-pyrrolo[2,3-b]pyridine |
| VENE-019 | 98549-88-3Available | 1H-pyrrolo[2,3-b]pyridin-5-ol |
| VENE-027 | 392-09-6Available | methyl 2-fluoro-4-nitrobenzoate |
| VENE-028 | 1667739-34-5Available | methyl 2-((1H-pyrrolo[2,3-b]pyridin-5-yl)oxy)-4-nitrobenzoate |
| VENE-029 | 1667739-35-6Available | methyl 2-((1H-pyrrolo[2,3-b]pyridin-5-yl)oxy)-4-aminobenzoate |
| VENE-030 | 334-22-5Available | bis(2-chloroethyl)amine |
| VENE-031 | 1257044-57-7Available | methyl 2-((1H-pyrrolo[2,3-b]pyridin-5-yl)oxy)-4-(piperazin-1-yl)benzoate |
| VENE-032 | 1667739-36-7Available | (4'-chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)methyl methanesulfonate |
Frequently asked questions
What are the approved indications of Venetoclax?
Approved indications include: 急性髓细胞样白血病, 慢性淋巴细胞白血病.
When does the Venetoclax patent expire?
Based on public sources, the Venetoclax patent expires in 2030.
How many synthesis routes are recorded for Venetoclax?
3 synthesis routes are recorded; the shortest is 6 steps with 98.00 mg total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Venetoclax intermediates?
31 intermediate CAS of Venetoclax are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.
How do I get a quote for Venetoclax intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24